GLP-1 Drug Lawsuits: Patients Allege Severe Side Effects, Blindness

Growing Lawsuits Against GLP-1 Drugmakers

• ⚖️ Over 3,000 patients have filed lawsuits against manufacturers of popular GLP-1 weight loss drugs like Ozempic, WGO, Mounjaro, and Zepbound.
• ⚠️ Plaintiffs allege that companies like Novo Nordisk and Eli Lilly failed to adequately warn them about severe health risks.

Alleged Severe Side Effects

• 👁️ A primary concern raised in the lawsuits is the alleged risk of vision loss or blindness.
• 💔 Other severe undisclosed side effects mentioned include gastrointestinal injuries, loss of brain function, eyesight, and even organs.
• 💀 Some lawsuits reportedly include claims of patient deaths due to serious bowel conditions.

Legal and Corporate Responses

• 🧑‍⚖️ Attorneys for the plaintiffs are gathering large amounts of data to establish correlations between the drugs and the alleged side effects.
• 🛡️ Drugmakers, including Eli Lilly and Novo Nordisk, have strongly pushed back against the allegations.
• 📄 Companies state that patient safety is a top priority and that their FDA-approved labels include robust warnings for potential adverse reactions.
• 🔬 Novo Nordisk has pointed to hundreds of clinical trials supporting the safety and efficacy of their popular drugs.